This collection explores advances in targeted cancer therapies and highlighted treatment strategies for various cancers, including non-small cell lung cancer, hormone receptor-positive breast cancer, and renal cell carcinoma. It emphasizes the role of genetic mutations in treatment decisions, the implementation of biomarkers, and the importance of genetic testing in cancer care. Additionally, the challenges of cost and accessibility of targeted therapies, along with the integration of immunotherapy in treatment protocols are discussed, aiming at personalized healthcare solutions for patients.
HER2-Mutant NSCLC: Closing the Gap Between Detection and Optimal Treatment
